Phocas Financial Corp. Invitae Corp Transaction History

Phocas Financial Corp.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 25, 2022	SELL	$6.28 - $15.59 $630,669 - $1.57 Million	-100,425 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$14.7 - $28.67 $34,530 - $67,345	-2,349 Reduced 2.29%	100,425 $1.53 Million
Q3 2021 Nov 16, 2021	BUY	$24.31 - $33.6 $25,744 - $35,582	1,059 Added 1.04%	102,774 $2.92 Million
Q2 2021 Aug 16, 2021	BUY	$26.09 - $40.4 $2.65 Million - $4.11 Million	101,715 New	101,715 $3.43 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.